
{
  "Company Overview": {
    "Name": "Epigral Ltd",
    "Sector": "Chemicals",
    "Industry": "Chlor Alkali / Soda Ash",
    "Business Description": "Leading integrated manufacturer of chemicals in India.  The Dahej facility is a backward and forward integrated and automated complex. First in India to set up an Epichlorohydrin plant and has the largest capacity plant of CPVC Resin.  Leading manufacturer of Caustic Soda, Caustic Potash, Chloromethanes, Hydrogen Peroxide, Chlorine and Hydrogen.",
    "Market Position": "5th largest producer of Chloromethanes (CMS) in India; 3rd largest producer of Hydrogen Peroxide in India"
  },
  "Financial Metrics": {
    "Market Cap": "₹ 8,482 Cr.",
    "Current Price": "₹ 1,966",
    "High / Low": "₹ 2,408 / 900",
    "Stock P/E": 29.0,
    "Book Value": "₹ 337",
    "Dividend Yield": "0.25 %",
    "ROCE": "17.5 %",
    "ROE": "16.9 %",
    "Face Value": "₹ 10.0",
    "Debt-to-Equity Ratio": null //Not explicitly provided in HTML
  },
  "Performance Trends": {
    "Quarterly Results": {
      "Sales": [340, 422, 499, 533, 556, 538, 562, 455, 478, 472, 525, 651, 626],
      "Expenses": [239, 281, 324, 345, 375, 371, 407, 360, 370, 349, 369, 475, 448],
      "Operating Profit": [101, 141, 175, 187, 180, 167, 155, 95, 108, 123, 155, 176, 178],
      "OPM %": ["30%", "33%", "35%", "35%", "32%", "31%", "28%", "21%", "23%", "26%", "30%", "27%", "28%"],
      "Other Income": [2, -0, 2, 2, 2, -0, 5, 2, 1, 2, 2, 2, 6],
      "Interest": [10, 10, 12, 11, 14, 21, 19, 18, 21, 20, 14, 14, 27],
      "Depreciation": [22, 22, 21, 22, 26, 31, 30, 31, 32, 31, 30, 33, 32],
      "Profit before tax": [71, 109, 144, 156, 142, 114, 110, 48, 56, 74, 113, 131, 124],
      "Tax %": ["34%", "36%", "31%", "31%", "35%", "33%", "30%", "33%", "32%", "34%", "32%", "34%", "35%"],
      "Net Profit": [47, 70, 99, 108, 92, 77, 77, 32, 38, 49, 77, 86, 81],
      "EPS in Rs": [11.31, 16.78, 23.85, 25.94, 22.04, 18.58, 18.48, 7.62, 9.18, 11.87, 18.45, 20.70, 19.38]
    },
    "Annual Results": {
      "Sales": [394, 392, 598, 710, 611, 829, 1551, 2188, 1929, 2273],
      "Expenses": [245, 248, 346, 405, 416, 567, 1041, 1499, 1448, 1640],
      "Operating Profit": [149, 144, 252, 306, 194, 261, 510, 689, 481, 633],
      "OPM %": ["38%", "37%", "42%", "43%", "32%", "32%", "33%", "31%", "25%", "28%"],
      "Other Income": [2, 1, 8, 16, 2, 2, 4, 8, 6, 12],
      "Interest": [19, 14, 9, 25, 11, 29, 44, 66, 73, 75],
      "Depreciation": [44, 55, 55, 54, 44, 74, 86, 109, 124, 127],
      "Profit before tax": [88, 75, 195, 242, 141, 161, 383, 523, 291, 443],
      "Tax %": ["23%", "11%", "20%", "25%", "21%", "37%", "34%", "32%", "33%", null],
      "Net Profit": [67, 67, 155, 183, 112, 101, 253, 353, 196, 293],
      "EPS in Rs": [9.49, 9.40, 21.97, 44.38, 27.19, 24.48, 60.84, 85.04, 47.12, 70.40]
    },
    "Balance Sheet Highlights": {
      "Equity Capital": [71, 71, 71, 41, 42, 42, 42, 42, 42, 42],
      "Reserves": [224, 291, 447, 241, 331, 432, 684, 1028, 1213, 1358],
      "Borrowings": [190, 123, 74, 601, 737, 753, 993, 879, 964, 904],
      "Other Liabilities": [55, 42, 79, 162, 164, 223, 405, 484, 576, 676],
      "Total Liabilities": [540, 527, 671, 1044, 1273, 1449, 2124, 2432, 2794, 2979],
      "Fixed Assets": [364, 398, 347, 295, 440, 1102, 1068, 1804, 1767, 1912],
      "CWIP": [69, 3, 79, 468, 691, 126, 589, 158, 483, 350],
      "Investments": [0, 29, 71, 0, 0, 0, 0, 21, 21, 21],
      "Other Assets": [106, 98, 173, 281, 142, 221, 467, 449, 524, 696],
      "Total Assets": [540, 527, 671, 1044, 1273, 1449, 2124, 2432, 2794, 2979]
    },
    "Cash Flow Summaries": {
      "Cash from Operating Activity": [165, 229, 284, 626, 398, null, null, null, null, null],
      "Cash from Investing Activity": [-363, -197, -455, -437, -401, null, null, null, null, null],
      "Cash from Financing Activity": [69, -32, 195, -200, -8, null, null, null, null, null],
      "Net Cash Flow": [-129, 1, 24, -11, -11, null, null, null, null, null]
    }
  },
  "Ratios": {
    "Growth Ratios": {
      "Compounded Sales Growth (10 Years)": null,
      "Compounded Sales Growth (5 Years)": "22%",
      "Compounded Sales Growth (3 Years)": "33%",
      "Compounded Sales Growth (TTM)": "12%",
      "Compounded Profit Growth (10 Years)": null,
      "Compounded Profit Growth (5 Years)": "2%",
      "Compounded Profit Growth (3 Years)": "25%",
      "Compounded Profit Growth (TTM)": "31%",
      "Stock Price CAGR (10 Years)": null,
      "Stock Price CAGR (5 Years)": null,
      "Stock Price CAGR (3 Years)": "39%",
      "Stock Price CAGR (1 Year)": "118%"
    },
    "Liquidity Ratios": null, //Not explicitly provided in HTML
    "Profitability Ratios": {
      "Return on Equity (10 Years)": null,
      "Return on Equity (5 Years)": "30%",
      "Return on Equity (3 Years)": "30%",
      "Return on Equity (Last Year)": "17%",
      "ROCE (10 Years)": null,
      "ROCE %": [18, 37, 36, 15, 16, 29, 32, 17]
    },
    "Valuation Ratios": null, //Partially provided (P/E), but others not explicitly stated.
    "Other Ratios": {
      "Debtor Days": [43, 41, 47, 40, 46, 52, 60, 28, 34],
      "Inventory Days": [75, 59, 45, 58, 64, 51, 74, 69, 90],
      "Days Payable": [31, 37, 51, 52, 62, 69, 42, 36, 57],
      "Cash Conversion Cycle": [86, 63, 42, 46, 48, 34, 92, 61, 67],
      "Working Capital Days": [43, 40, 19, -26, -65, -59, 26, 15, 25]
    }
  },
  "Peer Comparison": {
    "Peers": [
      {"Name": "Gujarat Alkalies", "CMP": 743.85, "P/E": null, "Mar Cap": 5462.83, "Div Yld": 0.00, "NP Qtr": -18.18, "Qtr Profit Var": 1.03, "Sales Qtr": 990.73, "Qtr Sales Var": 2.00, "ROCE": -3.83},
      {"Name": "Andhra Sugars", "CMP": 94.08, "P/E": 22.46, "Mar Cap": 1275.12, "Div Yld": 1.06, "NP Qtr": 5.03, "Qtr Profit Var": -76.35, "Sales Qtr": 528.42, "Qtr Sales Var": 2.03, "ROCE": 5.34},
      {"Name": "Tuticorin Alkali", "CMP": 93.41, "P/E": 18.27, "Mar Cap": 1138.07, "Div Yld": 0.00, "NP Qtr": 13.87, "Qtr Profit Var": -27.27, "Sales Qtr": 74.42, "Qtr Sales Var": -16.92, "ROCE": 146.32},
      {"Name": "TGV Sraac", "CMP": 104.55, "P/E": 20.97, "Mar Cap": 1119.62, "Div Yld": 0.96, "NP Qtr": 32.90, "Qtr Profit Var": 960.45, "Sales Qtr": 428.06, "Qtr Sales Var": 18.79, "ROCE": 5.12},
      {"Name": "Primo Chemicals", "CMP": 38.12, "P/E": null, "Mar Cap": 923.81, "Div Yld": 0.00, "NP Qtr": 13.26, "Qtr Profit Var": 197.72, "Sales Qtr": 134.36, "Qtr Sales Var": 44.16, "ROCE": -2.47},
      {"Name": "Lords Chloro", "CMP": 167.08, "P/E": null, "Mar Cap": 420.21, "Div Yld": 0.00, "NP Qtr": 0.36, "Qtr Profit Var": 129.51, "Sales Qtr": 60.62, "Qtr Sales Var": 25.98, "ROCE": -2.62}
    ],
    "Median": {
      "CMP": 104.55,
      "P/E": 21.71,
      "Mar Cap": 1138.07,
      "Div Yld": 0.0,
      "NP Qtr": 13.26,
      "Qtr Profit Var": 111.2,
      "Sales Qtr": 428.06,
      "Qtr Sales Var": 18.79,
      "ROCE": 5.12
    }
  },
  "Other Insights": {
    "Pros": "Company has a good return on equity (ROE) track record: 3 Years ROE 30.2%",
    "Cons": "Promoter holding has decreased over last quarter: -2.64%",
    "Disclaimer": "The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.",
    "Shareholding Pattern Notes": "* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards. Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes."
  },
  "Indices": [
    "BSE SmallCap",
    "BSE Allcap",
    "BSE Commodities",
    "Nifty Microcap 250",
    "Nifty Total Market"
  ]
}
